The Pharmaceutical Excipients Market is poised for significant growth between 2025 and 2035, driven by the increasing demand for drug formulations and advancements in the pharmaceutical industry.

Whether acquisition or IPO, we live and die by building businesses that scale. But how do you know it's time to sell, or how ...

As the Oval Office and Congress flip to Republican control, we expect more state AG-led efforts to impact public policy. Shortly after ...

CyberArk , the global leader in identity security, today announced it has acquired Zilla Security, a leader in modern Identity Governance and Administration (IGA) solutions. Zilla's innovative, ...

Verizon Communications (VZ) has disclosed a new risk, in the Corporate Activity and Growth category. Verizon Communications faces considerable ...

The Japanese companies’ decision to call off negotiations highlights the challenges legacy automakers face in partnering to ...

According to a recent KPMG report, the global M&A landscape in 2024 signals a rebound despite challenges like geopolitical tensions, high interest rates, and persistent inflation for much of the year.

M&A expert John D. Wagner shares proven, practical steps that you can take today that will help drive up your company's acquisition value.

Imerys has been recognized with an A rating on the CDP Corporate Climate A List for 2024, an improvement from its B score in 2023, underscoring t ...